NEW YORK (

TheStreet

) --

Rite Aid

(RAD) - Get Report

was one of several stocks trading near $5 poised to move on above-average volume Wednesday after reported a first-quarter loss that came in ahead of analysts' forecasts.

Rite Aid

said it had a first-quarter loss of 9 cents a share, narrower than the Thomson Reuters average analyst estimate for a loss of 14 cents a share in the quarter. Sales were down 2.1% from the year-ago quarter to $6.39 billion, which was in line with consensus.

Looking ahead, Rite Aid reaffirmed its earnings and revenue guidance for the full year, saying it expects a loss of 41 cents to 65 cents a share on revenue of $25.2 billion to $25.6 billion. Analysts are looking for a full-year loss of 52 cents a share on revenue of $25.42 billion, according to Thomson Reuters.

Shares of Rite Aid rose by 5 cents, or 5%, to $1.06 in the premarket session. The three-month average daily volume for Rite Aid is 8.01 million, according to Yahoo! Finance.

Elsewhere,

Chimera Investment

(CIM) - Get Report

TST Recommends

slipped by 10 cents, or 2.6%, to $3.72 in the premarket session after the company announced a public offering of 100,000 shares of common stock. Net proceeds will be used to finance the acquisition of residential and commercial mortgage-backed securities, mortgage loans and other securities. The three-month average daily volume for Chimera is 15.96 million.

TomoTherapy

( TOMO) gained 10 cents, or 3.6%, to $2.85 in Tuesday's after-market session after the company said it signed a services deal with

Amerinet

to make its radiation therapy systems available to Amerinet's members. The 50-day average daily volume for TomoTherapy is 248,000, according to the

Nasdaq

.

-- Written by Robert Holmes in Boston

.

Check out all of Wednesday's high-volume, under-$5 stocks at the Dollar Store. View the Dollar Store portfolio on StockPickr.

Follow Robert Holmes on

Twitter

and become a fan of TheStreet.com on

Facebook.